Agile Therapeutics Inc (AGRX)
0.4048
-0.03
(-7.90%)
USD |
OTCM |
May 02, 16:00
Agile Therapeutics Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 99.99% |
| January 31, 2024 | 99.98% |
| December 31, 2023 | 99.98% |
| November 30, 2023 | 99.98% |
| October 31, 2023 | 99.98% |
| September 30, 2023 | 99.98% |
| August 31, 2023 | 99.98% |
| July 31, 2023 | 99.97% |
| June 30, 2023 | 99.97% |
| May 31, 2023 | 99.96% |
| April 30, 2023 | 99.93% |
| March 31, 2023 | 99.90% |
| February 28, 2023 | 99.90% |
| January 31, 2023 | 99.90% |
| December 31, 2022 | 99.90% |
| November 30, 2022 | 99.89% |
| October 31, 2022 | 99.87% |
| September 30, 2022 | 99.86% |
| August 31, 2022 | 99.81% |
| July 31, 2022 | 99.77% |
| June 30, 2022 | 99.49% |
| May 31, 2022 | 99.39% |
| April 30, 2022 | 98.93% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.06% |
| February 28, 2022 | 98.06% |
| January 31, 2022 | 98.06% |
| December 31, 2021 | 98.06% |
| November 30, 2021 | 98.06% |
| October 31, 2021 | 98.06% |
| September 30, 2021 | 98.06% |
| August 31, 2021 | 98.06% |
| July 31, 2021 | 98.06% |
| June 30, 2021 | 98.06% |
| May 31, 2021 | 98.06% |
| April 30, 2021 | 98.06% |
| March 31, 2021 | 98.06% |
| February 28, 2021 | 98.06% |
| January 31, 2021 | 98.06% |
| December 31, 2020 | 98.06% |
| November 30, 2020 | 98.06% |
| October 31, 2020 | 98.06% |
| September 30, 2020 | 98.06% |
| August 31, 2020 | 98.06% |
| July 31, 2020 | 98.06% |
| June 30, 2020 | 98.06% |
| May 31, 2020 | 98.06% |
| April 30, 2020 | 98.06% |
| March 31, 2020 | 98.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.06%
Minimum
May 2019
100.00%
Maximum
Apr 2024
98.81%
Average
98.06%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Altimmune Inc | 99.85% |
| iBio Inc | 99.97% |
| Verastem Inc | 97.04% |
| Oragenics Inc | 98.92% |
| Actinium Pharmaceuticals Inc | 97.29% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -98.90 |
| Beta (5Y) | 1.252 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.6% |
| Historical Sharpe Ratio (5Y) | -0.775 |
| Historical Sortino (5Y) | -1.458 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.31% |